Medicine II Homework January 6, 2010 Subsection B4 Facilitator: Remedios F. Coronel, M.D.

Slides:



Advertisements
Similar presentations
Infections in the Immunocompromised Host
Advertisements

2. Define Febrile Neutropenia occurs when a patient has a fever and a significant reduction in their white blood cells (neutropenia) that are needed to.
Dr. Kouros Aghazade Shahid Beheshti Medical University
SEPSIS KILLS program Adult Inpatients
OPPORTUNISTIC FUNGAL INFECTIONS
Identify patient at risk for Candida infection Major risk factors includeOther risk factors include Previous bacterial infection and therapy Tunneled venous.
ANTIFUNGAL DRUGS.
Initial Antifungal Therapy for Critical Ill Patients When and Which ? 林口長庚 胸腔內科 林鴻銓 Lin, Horng-Chyuan Division of Pulmonary Infectious & Immunological.
Wes Theurer, DO.  Recognize sepsis early  Understand therapeutic principles  Cultures before antibiotics  Crystalloid fluid resuscitation  Antimicrobials.
Febrile Neutropenia Allison Ferrara, MD Princeton Baptist Medical Center Baptist Health Systems Alabama.
Severe Sepsis Initial recognition and resuscitation
Early Goal Therapy in Severe Sepsis & Septic Shock
Pam Charity, MD Cathryn Caton, MD, MS.  Define pneumonia  Review criteria for diagnosis  Review criteria for admission  Review treatment options.
Pneumonia and Sepsis By Oliver Putt and Priyanca Patel For WMS Peer Support – 11 th November 2014.
Management of Neutropenic Fevers in cancer patients Jerry Yu.
Management of Neutropenic Sepsis Rebecca Frewin Consultant Haematologist Gloucestershire Hospitals NHS Foundation Trust.
Nov 2007 ACoRN © Infection Sequence. Nov 2007ACoRN ©
Which drugs?. Mode of action of antifungals ergosterol polyenes e.g. amphotericin B polyenes azoles e.g. fluconazole azoles nucleosides e.g. 5-flucytosine.
Sepsis and Early Goal Directed Therapy
SEPTIC SHOCK University of Medicine and Pharmacy, Iasi School of Medicine ANESTHESIA and INTENSIVE CARE Conf. Dr. Ioana Grigoras MEDICINE 4 th year English.
Response to foreign body Inflammatory reaction –Localized –Generalized Generalized inflammatory reaction –Infective –Noninfective Sepsis: Generalized inflammatory,
Life-Threatening Infections: Diagnosis and Antimicrobial Therapy Selection.
Antimicrobial treatment for Systemic Candidiasis.
Clare Dikken Macmillan Senior Chemotherapy Nurse Sussex Cancer Network
Copyright 2008 Society of Critical Care Medicine
Sepsis.
Infections In The Immunocompromised Host
National Sepsis Audit National Registrar Research Collaborative Audit Project 2013 Nationally led by SPARCS (Severn and Peninsula Audit and Research Collaborative.
Initial Management of Fever or Suspected Infection In Paediatric Oncology and Stem Cell Transplantation Patients Clinical Practice Guideline 1 st edition.
Sepsis. 54 year old man with a past history of smoking and diabetes presents to the emergency department with a one week history of progressive unwellness.
DRUG INTERACTIONS. –Adverse drug effects –Hypersensitivity –Anaphylactic reactions.
Severe sepsis and Septic Shock. Anaphylactic shock Hypovolemic shock Cardiogenic shock Neurogenic shock Septic Shock.
United States Statistics on Sepsis
Neutropenic Sepsis (NS)
Candidaemia in Critically Ill Patients Dr Bunny Saberwal, Mrs Rakhee Patel, Dr Seng Zhi Quan and Dr A. Gonzalez ICE 2.
Managing Candidemia JEANNE FORRESTER, PHARMD, BCPS PGY2 INFECTIOUS DISEASES PHARMACY RESIDENT MEDICAL UNIVERSITY OF SOUTH CAROLINA.
Fungal endophthalmitis
Dr C Sriruttan Clinical Microbiology & Infectious Disease /11/20161 Principles & Approach.
BY lecturer / Hend Hamdey Rashed Clinical oncology & Nuclear medicine.
Outline of the Presentation
Empirical versus Preemptive Antifungal Therapy for High-Risk, Febrile, Neutropenic Patients: A Randomized, Controlled Trial Clinical Infectious Diseases.
MANAGEMENT OF NEUTROPENIC FEVERS IN CANCER PATIENTS Jerry Yu.
Introducing ‘Sepsis 6’ at RACH. Important definitions SIRS Sepsis Severe sepsis Septic shock.
Management of Adult Fever and Sepsis MLP EM Education Curriculum Dave Markel September 15, 2015.
Sepsis (adults) September 2015.
Clinical Case Conference #5 Amaro - Aribon. Pathomechanisms for Cytopenia in Active SLE.
Fungal Peritonitis (FP) Constantinos J. Stefanidis “P. and A. Kyriakou” Children’s Hospital Athens, Greece.
Sepsis Tutoring By Alaina Darby.
Yadegarynia, D. MD..
Antifungal drugs Lec Dr. Naza M. Ali
بنام خدا.
Sepsis.
CALS Instructor Update July 14, 2016
Diversity of Fungi and Fungal Infections
Clinical Case Conference #5
Infections In The Immunocompromised Host
Autoimmune Diseases Autoimmune Diseases Presented By Dr. Manal Yassin.
Staten Island University Hospital, Staten Island, New York, USA
Sepsis.
Fungal endophthalmitis
This slide set is meant to be used as an adjunct resource to the Medscape program titled “Managing Invasive Candidiasis: A Systematic Approach” by Thomas.
Intra-Abdominal Candidiasis, Candida peritonitis
Identifying and treating the stages of sepsis
Hypersensitivity reactions
Anemia of chronic disease =Anemia of chronic disorders (ACD)
بنام خداوند جان و خرد بنام خداوند جان و خرد.
Should I still screen for possible sepsis with SIRS criteria?
N.M.A. Blijlevens, J.P. Donnelly, B.E. de Pauw 
Community Acquired Pneumonia
Endocarditis is an inflammation of the endocardium, the membrane lining the chambers of the heart and covering the cusps of the heart valves. Infective.
Presentation transcript:

Medicine II Homework January 6, 2010 Subsection B4 Facilitator: Remedios F. Coronel, M.D.

Patho-mechanisms for Cytopenia in Active SLE Anemia – Auto-antibodies to red cells as part of the auto- immunity – Impaired erythropoietin production by kidneys involved in the SLE – Gastrointestinal blood loss from anti-inflammatory therapy – Increased red cell destruction from hypersplenism – Drug-induced immune phenomenon Lam SKLam SK, Quah TC. Anemia in systemic lupus erythematosus. J Singapore Paediatr Soc. 1990;32(3-4):132-6.Quah TC

Patho-mechanisms for Cytopenia in Active SLE Leukopenia specifically lymphopenia – Cytotoxic activity against allogeneic and autologous lymphocytes – Direct lysis of lymphocytes by complement Thrombocytopenia – Autoantibody-mediated (Anti-GPIIb/IIIa and anti- TPOR antibodies M. Kuwana, J. Kaburaki, Y. Okazaki, H. Miyazaki and Y. Ikeda. Two types of autoantibody-mediated thrombocytopenia in patients with systemic lupus erythematosus. Rheumatology (7): P. Stastny and M. Ziff. Antibodies against cell membrane constituents in systemic lupus erythematosus and related diseases. I. Cytoxic effect of serum from patients with systemic lupus erythematosus (SLE) for allogenic and for autologous lymphocytes. Clin Exp Immunol April; 8(4): 543–550.

Febrile Neutropenia A medical emergency marked by fever and an abnormally low neutrophil count that could be fatal in a matter of hours Infectious Disease Society of America 2002 – Temperature of 38.5°C associated with a ANC of 0.5x10 9 /L or a temperature of 38°C for 1 hour – ANC <1.0x 10 9 /L with a predicted decrease to <0.5 If early neutropenia <10-14 days

Risk Factors for Candidiasis Use of antibacterial agents Indwelling intravascular catheters Hyperalimentation fluids Indwelling urinary catheters Parenteralglucocorticoids Respirators Neutropenia Abdominal and thoracic surgery Cytotoxic chemotherapy Immunosuppressive agents for organ transplantation

Antimicrobial Treatment for Systemic Candidiasis Candidemia – Associated with several days of fever unresponsive to antimicrobials, prolonged IV catheterization, multi organ infection – others: intravascular catheter-related candidiasis, suppurative thrombophlebitis, endocarditis Disseminated Candidiasis – Frequently associated with multiple deep organ infections or may involve single organ infection – Candida osteomyelitis, arthritis, endocarditis, pericarditis, and meningitis, requires prolonged antifungal therapy for at least 4-6 weeks – The history of a patient with presumptive disseminated candidiasis reveals a fever unresponsive to broad- spectrum antimicrobials and negative results from blood culture Systemic Candidiasis: Two Primary Syndromes

Antimicrobial Agents DRUGINDICATIONREMARKS Azole - Fluconazole (IV/oral) - Drug of choice in most cases of candidemia and disseminated candidiasis (in non- neutropenic and hemodynamicaly stable patients - Lower nephrotoxicity rates (<2%) and ease of use because of the high degree of bioavailability and the long half-life of the drug - Voriconazole (IV/Oral) - If additional mold coverage is desired - Used in neutropenic and hemodynamicaly unstable patients Echinocandins (Capsofungin IV) - Recommended for candidemia in most patients with neutropenia - Caspofungin is a broad- spectrum - An effective alternative for severe mucosal infections and systemic infections due to Candida, especially those due to non-albicans Candida species

- Recommended for candidemia in most patients with neutropenia; A broad-spectrum sem-isynthetic echinocandin; An effective alternative for severe mucosal infections and systemic infections due to Candida, especially those due to non-albicans Candida species such as C glabrata - An effective alternative for severe mucosal infections and systemic infections due to Candida, especially those due to non-albicans Candida species such as C glabrata; Can be initiated as a 70mg loading dose, followed by 50 mg/d intravenously to complete a minimum of 2 weeks of antifungals after improvement and after blood cultures have cleared Anudilafungin IV - Anidulafungin is a broad- spectrum echinocandin; An effective alternative for severe mucosal infections and systemic infections due to candida - Be initiated as a 200mg loading dose, followed by 100mg intravenously to complete a minimum of 2 weeks of antifungals after improvement and after blood cultures have cleared Micafungin IV - Has been shown to be an effective alternative for severe mucosal infections and systemic infections due to Candida, especially those due to non- albicans Candida species - Administered at 100 mg/d intravenously to complete a minimum of 2 weeks of antifungals after improvement and after blood cultures have cleared

Sepsis and Septic Shock Systemic inflammatory response syndrome (SIRS) – Two or more of the following conditions: (1) fever (oral temperature >38°C) or hypothermia ( 24 breaths/min); (3) tachycardia (heart rate >90 beats/min); (4) leukocytosis (>12,000/L), leukopenia ( 10% bands – May have a non-infectious etiology Sepsis – SIRS that has a proven or suspected microbial etiology Septic shock – Sepsis with hypotension (arterial blood pressure <90 mmHg systolic, or 40 mmHg less than the normal blood pressure of the patient) for at least 1 hour despite adequate fluid resuscitation – Need for vasopressors to maintain systolic blood pressure 90 mmHg or mean arterial pressure 70 mmHg

References Harrison’s Principles of Internal Medicine 17 th Edition Lam SK, Quah TC. Anemia in systemic lupus erythematosus. J Singapore Paediatr Soc. 1990;32(3-4): P. Stastny and M. Ziff. Antibodies against cell membrane constituents in systemic lupus erythematosus and related diseases. I. Cytoxic effect of serum from patients with systemic lupus erythematosus (SLE) for allogenic and for autologous lymphocytes. Clin Exp Immunol April; 8(4): 543–550.